Dr. Eric A. Rose, M.D. has a substantial background in medicine, holding an M.D. from a recognized medical school. He became the CEO of SIGA Technologies, Inc. on March 1, 2007, where he worked until December 31, 2010. During his...

Dr. Eric A. Rose, M.D. has a substantial background in medicine, holding an M.D. from a recognized medical school. He became the CEO of SIGA Technologies, Inc. on March 1, 2007, where he worked until December 31, 2010. During his tenure, Dr. Rose was paid a steady salary of $400,000 with no bonuses awarded, reflecting a conservative approach to executive compensation. His employment agreement included provisions that ensured he would receive his salary for a year if terminated without cause. Most notably, he played a key role in guiding the company through significant changes and challenges in the pharmaceutical sector. After stepping down as CEO, he transitioned to the role of Executive Chairman, showing his lasting commitment to the company's vision. In terms of insider trading, Dr. Rose was active in managing his holdings, peaking in value at over $22 million in August 2022. This reflects both his confidence in SIGA and the trust investors place in his leadership.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other SIGA Technologies CEOs

S

Dr. Eric A. Rose, M.D.

Ex-CEO of SIGA Technologies

Education

M.D. from a recognized medical school

Field of Expertise

Healthcare & Life Sciences - Medicine

Sector of Economy

Healthcare

Born

January 1, 1963 - 62 years ago

CEO of SIGA Technologies for

3 years 9 months (Mar 2007 - Dec 2010)

Previous Experience

Medical doctor and executive in pharmaceutical industry

Rivals

Competitors/colleagues of Dr. Eric A. Rose, M.D.

Holdings

See how much did Dr. Eric A. Rose, M.D. make over time.

Dr. Eric A. Rose has demonstrated significant management of his stock holdings in SIGA Technologies. Between 2019 and 2024, his insider trading reported values fluctuated extensively, peaking at $22.39 million in August 2022. This high point shows a strong investor...

Dr. Eric A. Rose has demonstrated significant management of his stock holdings in SIGA Technologies. Between 2019 and 2024, his insider trading reported values fluctuated extensively, peaking at $22.39 million in August 2022. This high point shows a strong investor confidence during a critical period for the company. Over the years, his holdings have seen exciting movements, from around $5.73 million in late 2019 to impressive highs, but have also come down as of late 2024, indicating the volatility and potential of biotech investments. His involvement in the stock market reflects a keen insight into the company’s performance and its future prospects. Throughout the years, he maintained a strategic outlook on his trades reflecting his understanding of the biopharmaceutical industry.

Total Stock Sold

$564.82K

SIGA

$564.82K

41,500 SIGA shares

What if they kept their stock?

If Dr. Eric A. Rose, M.D. didn't sell their stock, today they would have:
Extra SIGA41,500 shares worth $222.86K.
This is -60.54% and $341.96K less than what they got when they sold the stock.

Insider Trading

See recent insider trades of Dr. Eric A. Rose, M.D..

OBIO

5,376 shares

OBIO

Jun 20, 2024

Received

SIGA

0 shares

SIGA

Jan 3, 2014

Purchase

SIGA

$566.48K

SIGA at $13.65/share

May 19, 2011

Sale

SIGA

490,000 shares

SIGA

May 17, 2011

Received

Compensation History

See how much did Dr. Eric A. Rose, M.D. make over time.

Dr. Eric A. Rose's compensation was straightforward during his time as CEO of SIGA Technologies. He received a consistent salary of $400,000 from 2007 through 2010, with no bonuses or stock options granted, which is quite unusual in the executive world. This indicated a more conservative approach to executive pay, aligning with a model that focused on company stability rather than extravagant rewards. The employment agreement also protected him with a clause that assured continued salary for a year if his position was terminated without cause. His compensation reflected both the company's focus on performance and a philosophy of tying executive rewards with shareholder interest. Dr. Rose subsequently transitioned to executive chairman, where he continued to influence company strategy and policy without the same compensation structure that he experienced as CEO.

Year

2010

Total Compensation

$400.00K

Salary

$400.00K

Board Justification

The compensation philosophy is designed to attract and retain the best possible executive talent, tie compensation to performance, and provide competitive compensation to align executives’ incentives with stockholder value.

Bonus

$0.00

Board Justification

Dr. Rose’s employment agreement does not provide for guaranteed bonus payments.

Other

$0.00

Board Justification

No other compensation was reported for 2010.

Restricted Stock

$0.00(0 common stock)

Board Justification

No stock grants were vested in 2010.

Performance Metrics

The performance metrics for determining compensation include individual performance, economic and business conditions affecting the Company, and the financial condition of the Company.

Other SIGA Technologies CEOs

Here are other CEOs of SIGA Technologies

Thomas N. Konatich

Ex-CEO of SIGA Technologies

April 2006 - February 2007

Dr. Phillip L. Gomez

Ex-CEO of SIGA Technologies

October 2016 - January 2024